Anticoagulants Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Feb 2019| TMR1380A| Transparency

Report Highlights

Anticoagulants Market - Overview

Anticoagulants prevent clot formation or enlargement of existing clots in the arteries or veins. Heparins, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH); vitamin K antagonists, DTIs, and factor Xa inhibitors, are the various anticoagulants available in the market. These are used for indications such as heart attack, stroke, deep venous thrombosis (DVT), pulmonary embolism (PE), surgery, angina, dialysis, atrial fibrillation (AF), thrombocytopenia, and myocardial infarction.

This report analyzes the current and future prospects of the global anticoagulants market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary researches. Detailed qualitative analysis of factors responsible for driving and restraining the market and opportunities has been provided in the overview section. Market revenue in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2018 to 2026 are provided for all the segments, considering 2017 as the base year. Market related factors such as technological developments, product innovation, and expansion of infrastructural facilities by major & small major products, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segments of the global anticoagulants market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, product development life cycle, and regulatory requirements. These factors would help the players to take strategic decisions in order to strengthen their positions and expand their share in the global market.

Based on route of administration, the global anticoagulants market has been bifurcated into oral and injectables. In terms of drug class, the market has been classified into factor Xa inhibitors (NOAC/DOAC), heparins, direct thrombin inhibitors, and vitamin K antagonists. Based on indication, the global anticoagulants market has been categorized into deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation & heart attack, and others. In terms of distribution channel, the market has been divided into hospital pharmacies, retail pharmacies, and online pharmacies.

Geographically, the global anticoagulants market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries/sub-regions. A global overview has been provided, and North America has been analyzed in depth at country as well as product, Indication, and end-user segment levels. North America includes the U.S. and Canada. Europe, Asia Pacific, Latin America, and Middle East & Africa have been briefly profiled at country level. Countries/sub-regions in these regions include the U.K., Germany, France, Italy, Spain, China, Japan, Australia & New Zealand, Brazil, Mexico, GCC Countries, and South Africa. The competition matrix section included in the report is likely to assist existing players to increase market shares and new companies to establish presence in the global anticoagulants market. The report also profiles major players in the global market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments.

Key players operating in the global anticoagulants market include Bayer Healthcare, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Limited, Johnson & Johnson Services, Inc., and Sanofi.

The global anticoagulants market has been segmented as follows:

Global Anticoagulants Market, by Route of Administration
Oral
Injectables

Global Anticoagulants Market, by Drug Class
Factor XA Inhibitors (NOAC/DOAC)
Heparins
Direct Thrombin Inhibitors
Vitamin K Antagonists

Global Anticoagulants Market, by Indication
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Atrial Fibrillation & Heart Attack
Others

Global Anticoagulants Market, by Distribution channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Anticoagulants Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

  • Table 1 : Global Anticoagulants Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 2 : Global Anticoagulants Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 3 : Global Anticoagulants Market Value (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 4 : Global Anticoagulants Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 5 : Global Anticoagulants Market Size (US$ Mn) and Volume (Units) Forecast, by Region, 2018–2026
  • Table 6 : North America Anticoagulants Market Value (US$ Mn) Forecast, by Country, 2016–2026
  • Table 7 : North America Anticoagulants Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 8 : North America Anticoagulants Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 9 : North America Anticoagulants Market Value (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 10 : North America Anticoagulants Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 11 : Europe Anticoagulants Size Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 12 : Europe Anticoagulants Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 13 : Europe Anticoagulants Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 14 : Europe Anticoagulants Market Value (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 15 : Europe Anticoagulants Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 16 : Asia Pacific Anticoagulants Size Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 17 : Asia Pacific Anticoagulants Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 18 : Asia Pacific Anticoagulants Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 19 : Asia Pacific Anticoagulants Market Value (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 20 : Asia Pacific Anticoagulants Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 21 : Latin America Anticoagulants Size Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 22 : Latin America Anticoagulants Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 23 : Latin America Anticoagulants Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 24 : Latin America Anticoagulants Market Value (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 25 : Latin America Anticoagulants Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 26 : Middle East & Africa Anticoagulants Size Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 27 : Middle East & Africa Anticoagulants Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 28 : Middle East & Africa Anticoagulants Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
  • Table 29 : Middle East & Africa Anticoagulants Market Value (US$ Mn) Forecast, by Indication, 2016–2026
  • Table 30 : Middle East & Africa Anticoagulants Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Figure 1 : Global Anticoagulants Market Size Value (US$ Mn) Forecast, 2016–2026
  • Figure 2 : Global Anticoagulants Market Value Share (%), by Route of Administration, 2018
  • Figure 3 : Global Anticoagulants Market Value Share (%), by Drug Class, 2018
  • Figure 4 : Global Anticoagulants Market Value Share (%), by End-user, 2018
  • Figure 5 : Global Anticoagulants Market Value Share (%), by Region, 2018
  • Figure 6 : Global Anticoagulants Market Value Share, by Route of Administration, 2018 and 2026
  • Figure 7 : Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Oral, 2016–2026
  • Figure 8 : Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Injectables, 2016–2026
  • Figure 9 : Global Anticoagulants Market Attractiveness, by Route of Administration, 2018–2026
  • Figure 10 : Global Anticoagulants Market Value Share, by Drug Class, 2018 and 2026
  • Figure 11 : Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Factor XA Inhibitors, 2016–2026
  • Figure 12 : Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Heparins, 2016–2026
  • Figure 13 : Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Direct Thrombin Inhibitors, 2016–2026
  • Figure 14 : Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Vitamin K Antagonists, 2016–2026
  • Figure 15 : Global Anticoagulants Market Attractiveness, by Drug Class, 2018–2026
  • Figure 16 : Global Anticoagulants Market Value Share, by Indication, 2018 and 2026
  • Figure 17 : Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Deep Vein Thrombosis (DVT), 2016–2026
  • Figure 18 : Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pulmonary Embolism (PE), 2016–2026
  • Figure 19 : Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Atrial Fibrillation & Heart Attack, 2016–2026
  • Figure 20 : Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
  • Figure 21 : Global Anticoagulants Market Attractiveness, by Indication, 2018–2026
  • Figure 22 : Global Anticoagulants Market Value Share, by Distribution Channel, 2018 and 2026
  • Figure 23 : Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals Pharmacies, 2016–2026
  • Figure 24 : Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies, 2016–2026
  • Figure 25 : Global Anticoagulants Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2016–2026
  • Figure 26 : Global Anticoagulants Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 27 : Global Anticoagulants Market Value Share Analysis, by Region, 2018 and 2026
  • Figure 28 : Global Anticoagulants Market Attractiveness Analysis, by Region, 2018 and 2026
  • Figure 29 : North America Anticoagulants Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
  • Figure 30 : North America Anticoagulants Market Value Share, by Country, 2018 and 2026
  • Figure 31 : North America Anticoagulants Market Attractiveness, by Country, 2018–2026
  • Figure 32 : North America Anticoagulants Market Value Share, by Route of Administration, 2018 and 2026
  • Figure 33 : North America Anticoagulants Market Attractiveness, by Route of Administration, 2018–2026
  • Figure 34 : North America Anticoagulants Market Value Share, by Drug Class, 2018 and 2026
  • Figure 35 : North America Anticoagulants Market Attractiveness, by Drug Class, 2018–2026
  • Figure 36 : North America Anticoagulants Market Value Share, by Indication, 2018 and 2026
  • Figure 37 : North America Anticoagulants Market Attractiveness, by Indication, 2018–2026
  • Figure 38 : North America Anticoagulants Market Value Share, by Distribution Channel, 2018 and 2026
  • Figure 39 : North America Anticoagulants Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 40 : Europe Anticoagulants Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
  • Figure 41 : Europe Anticoagulants Market Value Share, by Country/Sub-region, 2018 and 2026
  • Figure 42 : Europe Anticoagulants Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 43 : Europe Anticoagulants Market Value Share, by Route of Administration, 2018 and 2026
  • Figure 44 : Europe Anticoagulants Market Attractiveness, by Route of Administration, 2018–2026
  • Figure 45 : Europe Anticoagulants Market Value Share, by Drug Class, 2018 and 2026
  • Figure 46 : Europe Anticoagulants Market Attractiveness, by Drug Class, 2018–2026
  • Figure 47 : Europe Anticoagulants Market Value Share, by Indication, 2018 and 2026
  • Figure 48 : Europe Anticoagulants Market Attractiveness, by Indication, 2018–2026
  • Figure 49 : Europe Anticoagulants Market Value Share, by Distribution Channel, 2018 and 2026
  • Figure 50 : Europe Anticoagulants Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 51 : Asia Pacific Anticoagulants Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
  • Figure 52 : Asia Pacific Anticoagulants Market Value Share, by Country/Sub-region, 2018 and 2026
  • Figure 53 : Asia Pacific Anticoagulants Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 54 : Asia Pacific Anticoagulants Market Value Share, by Route of Administration, 2018 and 2026
  • Figure 55 : Asia Pacific Anticoagulants Market Attractiveness, by Route of Administration, 2018–2026
  • Figure 56 : Asia Pacific Anticoagulants Market Value Share, by Drug Class, 2018 and 2026
  • Figure 57 : Asia Pacific Anticoagulants Market Attractiveness, by Drug Class, 2018–2026
  • Figure 58 : Asia Pacific Anticoagulants Market Value Share, by Indication, 2018 and 2026
  • Figure 59 : Asia Pacific Anticoagulants Market Attractiveness, by Indication, 2018–2026
  • Figure 60 : Asia Pacific Anticoagulants Market Value Share, by Distribution Channel, 2018 and 2026
  • Figure 61 : Asia Pacific Anticoagulants Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 62 : Latin America Anticoagulants Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
  • Figure 63 : Latin America Anticoagulants Market Value Share, by Country/Sub-region, 2018 and 2026
  • Figure 64 : Latin America Anticoagulants Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 65 : Latin America Anticoagulants Market Value Share, by Route of Administration, 2018 and 2026
  • Figure 66 : Latin America Anticoagulants Market Attractiveness, by Route of Administration, 2018–2026
  • Figure 67 : Latin America Anticoagulants Market Value Share, by Drug Class, 2018 and 2026
  • Figure 68 : Latin America Anticoagulants Market Attractiveness, by Drug Class, 2018–2026
  • Figure 69 : Latin America Anticoagulants Market Value Share, by Indication, 2018 and 2026
  • Figure 70 : Latin America Anticoagulants Market Attractiveness, by Indication, 2018–2026
  • Figure 71 : Latin America Anticoagulants Market Value Share, by Distribution Channel, 2018 and 2026
  • Figure 72 : Latin America Anticoagulants Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 73 : Middle East & Africa Anticoagulants Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
  • Figure 74 : Middle East & Africa Anticoagulants Market Value Share, by Country/Sub-region, 2018 and 2026
  • Figure 75 : Middle East & Africa Anticoagulants Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 76 : Middle East & Africa Anticoagulants Market Value Share, by Route of Administration, 2018 and 2026
  • Figure 77 : Middle East & Africa Anticoagulants Market Attractiveness, by Route of Administration, 2018–2026
  • Figure 78 : Middle East & Africa Anticoagulants Market Value Share, by Drug Class, 2018 and 2026
  • Figure 79 : Middle East & Africa Anticoagulants Market Attractiveness, by Drug Class, 2018–2026
  • Figure 80 : Middle East & Africa Anticoagulants Market Value Share, by Indication, 2018 and 2026
  • Figure 81 : Middle East & Africa Anticoagulants Market Attractiveness, by Indication, 2018–2026
  • Figure 82 : Middle East & Africa Anticoagulants Market Value Share, by Distribution Channel, 2018 and 2026
  • Figure 83 : Middle East & Africa Anticoagulants Market Attractiveness, by Distribution Channel, 2018–2026

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report